US stock index futures surged following an agreement between the United States and China to scale back tariffs, easing trade war anxieties. The 90-day pause on additional trade measures includes tariff reductions, boosting market sentiment and driving gains in technology, growth, and energy stocks. However, pharmaceutical stocks declined due to President Trump’s plans to lower prescription drug prices.